logo

AVXL Stock Jumps On Lower Q4 Loss, Anticipation For EMA Approval Of Alzheimer’s Drug

(MENAFN – AsiaNet News) The company said its net loss for the three months through the end of September was $0.11 per share, down from a loss of $0.14 per share in the corresponding quarter of …

Read Full

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *